Emirates SkyCargo has further strengthened its temperature sensitive pharma and vaccine handling capabilities in Dubai with the extension of its fully automated cool room with 94 airline pallet positions at its EU GDP certified dedicated pharma facility at Dubai International Airport.
The extended cool room will provide an additional 2600sqm of temperature controlled environment (2-25 degrees Celsius) for the storage and handling of vaccines and other pharmaceuticals at Emirates SkyCargo’s purpose built GDP certified facility.
This has reinforced the carrier’s position as an industry leader for the air transportation of pharmaceuticals and providing additional capacity at its Dubai hub to meet the growing demand for transportation of Covid-19 vaccines. The new extension can hold an estimated 60-90 million doses of pandemic vaccines at one time.
Transportation of vaccines
Emirates SkyCargo continues to play a leading role in the international distribution of Covid-19 vaccines having transported over 75 million doses of vaccines on more than 250 flights to over 60 destinations since late 2020.
“Emirates SkyCargo is proud to have flown over 350 tonnes of vaccines around the world, delivering much needed support to communities that are still heavily impacted by the current wave of the pandemic. We expect to reach the 100 million doses milestone well before the end of this month,” said Nabil Sultan, Emirates Divisional Senior Vice President, Cargo.
Emirates SkyCargo also has more than 50 cool dollies dedicated for pharmaceuticals at its hub protecting temperature sensitive shipments such as vaccines during transit between the aircraft and the cargo terminal.
DP World partnership
In January 2020, Emirates SkyCargo joined hands with DP World, International Humanitarian City and Dubai Airports to form the Dubai Vaccine Logistics Alliance aimed at rapidly transporting Covid-19 vaccines through Dubai to developing countries.
This was shortly followed up in February 2020 with an MoU with UNICEF to expedite the transportation of Covid-19 vaccines under the COVAX initiative.